Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V.  The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading ->
Previous infection with COVID-19 protects most people against reinfection for over six months, but those over the age of 65 are more likely to get infected again, found a peer reviewed study published in The Lancet.  In the world’s first large-scale study of COVID-19 reinfections, researchers from Denmark, Sweden and the United Kingdom discovered that […] Continue reading ->
Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading ->
In just one year, COVID-19 has undone more than a decade’s progress in the fight against tuberculosis (TB), health experts said on Thursday. While COVID-19 fatality numbers are decreasing worldwide, TB-related deaths remain steady at 4000 cases a day – an occurrence experts partly attribute to limited access to TB treatment services during COVID lockdown […] Continue reading ->
The European Commission has released a proposal establishing a framework for a “Digital Green Certificate”, clearing the way for a vaccine certificate system to be set up by the summer.  The proposal comes as many European countries are witnessing a third wave of infections and as the region’s vaccination campaign is lagging from vaccine shortages […] Continue reading ->
South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks.  However, overall supplies remain far short of the needs – even for the health sector.  The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading ->
Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally.  The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading ->